Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,013 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Childhood Acute Lymphoblastic Leukaemia: Follow-Up

NCT03545659

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital Aarhus N, Denmark
  • Department of Paediatrics and Adolescent Medicine, Turku University Hospital Turku, Finland
  • The National University Hospital of Iceland Reykjavik, Iceland
  • Department of Childhood Oncology, University Hospital Tromsø Tromsø, Norway
View Trial Details
Completed

Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency

NCT02045017

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +19 more
Locations
  • Krankenhaus der Elisabethinen Linz, I Interne Abteilung Linz, Austria
  • Medizinische Universitat Wien Vienna, Austria
  • Wilhelminenspital der Stadt Wien Vienna, Austria
  • Hopital Dypuytren-CHU de Limoges Limoges, France
View all 22 locations
View Trial Details
Completed

Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT01767766

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
Locations
  • TG Therapeutics Trial Site Sarasota, Florida, United States
  • TG Therapeutics Trial Site Hackensack, New Jersey, United States
  • TG Therapeutics Trial Site New York, United States
  • TG Therapeutics Trial Site Durham, North Carolina, United States
View Trial Details
Completed

Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma

NCT00425555

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • University of Alabama at Birmingham/ Kirklin Clinic Kirklin Clinic Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Dept. of Hematology-Oncology Los Angeles, California, United States
  • Florida Academic Dermatology Center Miami, Florida, United States
View all 42 locations
View Trial Details

Related conditions